These include the human epidermal growth factor receptor-2 (HER-2), estrogen receptor (ER), progesterone receptor (PR) markers, and the triple-negative breast cancer (TNBC) markers, which further influence the tumor characteristics and prognosis. This evidence concerns the gene PGR and triple-negative breast carcinoma.